Vikram Chaudhery
Independent Director at Nureca
Vikram Chaudhery
Independent Director at Nureca
San Francisco, California
Overview
Work Experience
Founder, President & COO
2020 - Current
Partner
2019
Board Member
2021
Board Member
2022
Board Member
2021
Board Observer
2020 - 2021
Independent Director
2021
Investor
2021
Board Observer
2019 - 2023
Head of Life Sciences
2017 - 2019
Formulate acquisition strategy to build a new Life Sciences division for Lam Research, a leader in the semiconductor tools market. ► Led evaluation of new business opportunities for Lam in the life sciences industry. ++Led Lam's Life Sciences strategy in emerging businesses, corporate development ++Led all strategic planning activities across Genomics, Proteomics, Bioinformatics, Sample prep and Synthetic Biology: Market evaluation, segmentation, customer unmet needs, competitive analysis, technology diligence and strategic road mapping. ► Led all deal sourcing and deal structuring activities for investments, joint development agreements and acquisitions in life sciences ++Led all Life Sciences venture investments including Lam Antheia, Mission Bio, Ominiome ++Led the sourcing and diligence for joint development partnership with Nanostring ► Oversaw all investments and partnerships post close ++Member of joint-steering committee for partnership with Nanostring ++Primary business lead for all partnerships and investments ++Managed investment performance and fielded all support needs from engineering, nanofabrication and operations. ► Built scientific and commercial advisory boards and oversaw all consultancy partnerships ► Built and maintained relationships between venture, private organizations and academic institutions across the US and European innovation ecosystem
Engagement Manager
2013 - 2017
Management consulting to myriad of clients from Fortune 500 to startup. Led teams of industry experts, client executives and consultants to solve critical business problems for Fortune 500 Life Sciences corporations and leading biotechnology startup companies across the world. A handful of examples : ► Growth strategy for a Fortune 500 company ++Led in depth market analysis across Life Sciences ++ Led identification and diligence of minority investments, partnerships and acquisitions ++ Developed a portfolio based risk analysis approach for assessing assessing execution options ► Growth strategy for a med device company ++ Delivered sales strategies and launched pilot initiatives for 50+% growth two major assets into clinical space ► Growth and R&D strategy for a startup biotech ++ Streamlined a R&D strategy for clinical trials ++ Developed a financial forecasting tool for risked based analysis to inform portfolio expansion ► Due Diligence for major merger for a major pharma company ++ Pre-merger diligence and post merger synergy and transformation focused on operations strategy and supplier collaboration efforts ► Due diligence activity for healthcare private equity ++ Led Synergy assessment, deal structuring ++ Developed post acquisition transformation plan ► Comprehensive strategic sourcing transformation effort for a major Life Sciences company ++ Led restructuring of sourcing strategy for pharmacy, consumer medical devices and medical diagnostic equipment etc. ► Due-diligence and post merger integration in life sciences ++ Evaluated pre-merger synergy opportunities ++ Developed post-merger operating model, combined sourcing strategy, optimizing internal and external manufacturing and quality organization footprint